Bimekizumab for Plaque Psoriasis
At SOMA Skin & Laser, we offer the latest advancements in psoriasis treatment, including Bimekizumab, a next-generation biologic therapy for moderate to severe plaque psoriasis. If you’re struggling with persistent plaques, Bimekizumab may provide the relief you’ve been searching for.
What is Bimekizumab?
Bimekizumab is a dual IL-17A and IL-17F inhibitor, meaning it targets two key inflammatory cytokines responsible for driving psoriasis. By blocking both IL-17A and IL-17F, Bimekizumab offers a higher level of skin clearance compared to earlier biologics. Clinical trials have shown that many patients achieve clear or almost clear skin within weeks of starting treatment.
Benefits of Bimekizumab
- Rapid and sustained skin clearance
- Targets both IL-17A and IL-17F for enhanced effectiveness
- Convenient dosing schedule. Injected every 4 weeks for 16 weeks then every 8 weeks.
- Well-tolerated with a favorable safety profile
Who is a Candidate for Bimekizumab?
Bimekizumab is approved for adults with moderate to severe plaque psoriasis who may not have responded to other treatments. It is particularly effective for patients seeking long-lasting relief and reduced flare-ups.
What to Expect
Treatment with Bimekizumab involves a series of subcutaneous injections, typically starting with an initial dosing period followed by maintenance injections every few months. Our dermatology specialists at SOMA Skin & Laser will customize a treatment plan tailored to your needs.
Schedule a Consultation
If you’re ready to explore Bimekizumab for plaque psoriasis, our team at SOMA Skin & Laser is here to help. Contact us today to schedule a consultation and take the first step toward clearer, healthier skin.
Call us at 973-763-7546
Visit us at our Millburn, NJ or paramus, NJ Locations.
Book an appointment online [Your Website URL]
